Live Oak Bancshares, Inc. - Q2 2026 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2026. Live Oak Bancshares, Inc. operates primarily through its subsidiary, Live Oak Banking Company, a commercial bank specializing in lending to small businesses nationwide. A significant portion of its loan portfolio consists of loans partially guaranteed by the Small Business Administration (SBA) and the U.S. Department of Agriculture (USDA). The Company is a large accelerated filer.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | YTD 2026 (6 Months) | Balance Sheet (June 30, 2026) |
|---|---|---|---|
| Net Income (Common Shareholders) | $34.7 million | $62.6 million | N/A |
| Diluted EPS | $0.74 | $1.35 | N/A |
| Net Interest Income | $125.3 million | $244.7 million | N/A |
| Net Interest Margin | 3.33% | 3.30% | N/A |
| Provision for Credit Losses | $25.8 million | $45.9 million | N/A |
| Total Assets | N/A | N/A | $16.04 billion |
| Total Loans & Leases (Held for Investment) | N/A | N/A | $12.63 billion |
| Total Deposits | N/A | N/A | $14.55 billion |
| Shareholders' Equity | N/A | N/A | $1.32 billion |
| Cash & Due from Banks | N/A | N/A | $927.6 million |
Material Changes vs. Prior Period
- Profitability Surge: Net income attributable to common shareholders increased 48.1% year-over-year for Q2 2026 ($34.7M vs. $23.4M) and 89.0% for the six-month period ($62.6M vs. $33.1M). This was driven primarily by a $16.1M increase in net interest income and a $3.3M decrease in other noninterest expenses (excluding a one-time bioenergy lease loss in Q2 2025).
- Net Interest Income: Increased 14.8% in Q2 and 16.7% YTD compared to 2025, fueled by loan portfolio growth outpacing the growth in interest-bearing liabilities. The yield on average interest-earning assets decreased slightly (30 bps in Q2), while the cost of funds decreased more significantly (33 bps in Q2), expanding the net interest margin.
- Expense Management: Salaries and employee benefits increased by $2.8M in Q2 and $6.6M YTD due to strategic hiring. Conversely, "Other expense" dropped significantly ($3.3M in Q2) due to the absence of a $2.8M bioenergy lease loss recorded in the prior year.
- Asset Quality: Nonperforming assets (excluding fair value loans) decreased to $481.8 million from $509.4 million at year-end 2025. However, unguaranteed exposure within nonperforming assets increased to $127.4 million from $102.8 million.
Guidance, Outlook, Risks, and Unusual Items
- Subsequent Event: On July 28, 2026, the Company settled equity warrants held from a prior investment, receiving $8.7 million in cash proceeds and recognizing an $8.6 million realized gain. This will be reported in Q3 2026 noninterest income.
- Internal Control Weakness: Management concluded that disclosure controls and procedures were not effective as of June 30, 2026, due to a material weakness in internal control over financial reporting. The weakness relates to the accounting classification of loan participation activity in the Statement of Income and Statement of Cash Flows. A remediation plan is underway, with completion expected by the end of fiscal year 2026.
- Interest Rate Risk: The Company maintains a moderately asset-sensitive position. Simulations indicate that a 300 basis point increase in rates would increase Net Interest Income by 20.0% over the next 12 months, while a 300 basis point decrease would reduce it by 10.7%.
- Capital Position: The Company remains well-capitalized, with a Common Equity Tier 1 ratio of 10.42% (Consolidated) and 10.46% (Bank) as of June 30, 2026, significantly exceeding regulatory minimums.
Investor Verification Checklist
- Remediation Progress: Verify the status of the remediation plan for the material weakness in internal controls regarding loan participation accounting.
- Unguaranteed Exposure: Monitor the trend of unguaranteed exposure within nonperforming assets, which increased by 23.9% since December 2025.
- Q3 Impact: Confirm the recognition of the $8.6 million gain from the warrant settlement in the upcoming Q3 2026 filing.
- Cost of Funds: Assess the sustainability of the declining cost of funds (3.45% in Q2 2026) in the context of the broader interest rate environment.
- Loan Growth vs. Provision: Evaluate if the provision for credit losses ($25.8M in Q2) remains adequate given the 15.8% year-over-year growth in the loan portfolio.